Valuation: Illumina, Inc.

Market Cap 30.97B 26.92B 25.06B 23.01B 43.45B 2,956B 44.12B 295B 116B 1,472B 116B 114B 4,935B P/E 2026 *
42.1x
P/E 2027 * 35.3x
Enterprise Value 31.22B 27.14B 25.26B 23.19B 43.79B 2,980B 44.47B 298B 117B 1,484B 117B 115B 4,975B EV / Sales 2026 *
6.76x
EV / Sales 2027 * 6.17x
Free-Float
75.38%
Yield 2026 *
-
Yield 2027 * -
1 day+0.71%
1 week+5.67%
1 month+8.70%
3 months+51.05%
6 months+45.33%
Current year+56.37%
1 week 187.67
Extreme 187.67
205.93
1 month 178.88
Extreme 178.88
205.93
Current year 112.65
Extreme 112.65
205.93
1 year 88
Extreme 88
205.93
3 years 68.7
Extreme 68.7
205.93
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

167 0.0001%
30/06/26 Free

Director

142 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.00%+5.67%+116.67%+8.20% 30.97B
-0.43%+1.06%+24.03%+3.71% 212B
-0.61%+1.82%-1.07%-24.39% 137B
+0.10%+4.69%-26.86%+12.57% 125B
+1.59%+5.60%-55.67%-7.68% 69.46B
-0.98%+4.16%+8.50%+7.08% 49.56B
+5.85%+7.82%-17.08%-20.95% 47.2B
-0.25%-0.14%+21.91%+8.35% 39.08B
-0.79%+0.70%+29.97%+29.32% 37.05B
-2.75%+12.28%-2.62%-11.19% 30.72B
Average +0.27%+4.10%+9.78%+0.50% 77.83B
Weighted average by Cap. +0.29%+3.17%+3.66%-1.07%

Financials

2026 *2027 *
Net sales 4.62B 4.01B 3.74B 3.43B 6.48B 441B 6.58B 44.05B 17.29B 219B 17.34B 16.96B 736B 4.9B 4.26B 3.96B 3.64B 6.87B 468B 6.98B 46.71B 18.33B 233B 18.39B 17.99B 781B
Net income 748M 650M 605M 555M 1.05B 71.38B 1.07B 7.13B 2.8B 35.54B 2.81B 2.75B 119B 886M 770M 717M 658M 1.24B 84.54B 1.26B 8.45B 3.32B 42.09B 3.33B 3.25B 141B
Net Debt 246M 214M 199M 183M 345M 23.49B 350M 2.35B 921M 11.69B 924M 904M 39.21B -729M -634M -590M -542M -1.02B -69.59B -1.04B -6.95B -2.73B -34.65B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
31/07/26 US$205.10 +0.00% 4,099,921
30/07/26 US$205.09 +5.27% 2,770,354
29/07/26 US$194.82 +0.95% 1,694,087
28/07/26 US$192.98 +1.85% 2,112,806
27/07/26 US$189.47 -2.38% 1,738,894
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
205.10USD
Average target price
195.16USD
Spread / Average Target
-4.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock